Irinotecan hydrochloride

Cat. No.: X22-05-ZQ157

Irinotecan hydrochloride

Synonym: 100286-90-6; Irinotecan hydrochloride; Irinotecan HCl; [(19S)-10,19-Diethyl-19-Hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate;hydrochloride

  • MDL: MFCD01862255
  • CAS Number: 100286-90-6
  • Compound CID: 74990
Product Size
20 mg; 50 mg; 100 mg; 200 mg
Price
Datasheet
MSDS
Properties
Description
Irinotecan hydrochloride is an inhibitor of topoisomerase I (Topo I) that exhibits cytotoxicity in LoVo cells and HT-29 cells. This product can be used for research in the field of health care products and cosmetics.
Molecular Weight
623.14
Molecular Formula
C33H38N4O6·HCl
Purity
≥98%, determined by HPLC.
Stability
The product is stable for two years when stored at the recommended temperature.
Form
Powder
Identity
Confirmed by MS and NMR.
Applications
Irinotecan hydrochloride can be used for research in the field of health care products and cosmetics.
Storage
Store at 4°C. Protect from light.
Safety Information
Personal Protective Equipment
Gloves, eyeshields, N95 mask
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.